Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 30/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and HRZ (H-Isoniazid, R-Rifampin, Z-Pyrazinamide) treatment group.

Abundance in Group 1: increased abundance in HRZ(H-Isoniazid, R-Rifampin, Z-Pyrazinamide)

NCBI	Quality Control	Links
Acetatifactor
Akkermansia
Alistipes
Anaeroplasma
Anaerosporobacter
Anaerostipes
Anaerotruncus
Anaerovorax
Arthrobacter
Asaccharobacter
Bacteroides
Barnesiella
Blautia
Butyricicoccus
Christensenella
Dysgonomonas
Eisenbergiella
Enterorhabdus
Erysipelothrix
Erysipelotrichaceae
Ethanoligenens
Eubacterium
Flavonifractor
Intestinimonas
Lachnospiraceae
Mucispirillum
Oscillibacter
Pseudobacteroides
Pseudoflavonifractor
Roseburia
Tannerella
Thomasclavelia
Pediococcus

Revision editor(s): KateRasheed